active pharmaceutical ingredient articles & resources on Made-in-China.com

Fuisz Pharma Announces Issuance of Oral Thin Film Pharmaceutical Patent

Mar 7, 2018

Fuisz Pharma has announced the issuance of a new patent, US 9,901,545 (the “’545 Patent”) concerning the manufacture of oral thin film pharmaceuticals. The ‘545 Patent is entitled: “Method and composition for ...

Tags: Fuisz Pharma, Pharmaceutical Patent

SIO to Showcase New Range of Pharmaceutical Oils at CPhI 2016, Barcelona

Oct 8, 2016

SIO, an ADM company, will present a new range of innovative products and capabilities at CPhI 2016 in Barcelona. “Possessing more than 100 years of experience, SIO has a proud history of meeting the needs of pharmaceutical customers ...

Tags: SIO, CPhI 2016, pharmaceutical oil

Mylan Today Announced That Subsidiary Mylan Pharmaceuticals and Partner,Banner Pharmacaps

Dec 19, 2013

Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. and partner, Banner Pharmacaps Inc. (a wholly-owned subsidiary of Patheon Inc.), have entered into a settlement and license agreement with Eisai Inc. ...

Tags: Mylan, Targretin Suit, Treatment of Cutaneous Manifestations

Taiwan-Based JHL Biotech and Selexis Formed a Biologic Drug Development Alliance

Dec 5, 2013

Taiwan-based JHL Biotech and Switzerland-based Selexis have formed a biologic drug development alliance to serve the biopharmaceutical industry. JHL Biotech and Selexis have signed a non-exclusive strategic agreement to provide seamless ...

Tags: Health, Medicine, taiwan, Biologic Drug

Imprimis Pharmaceuticals Has Received Approval From The Institutional Review Board

Jul 26, 2013

Imprimis Pharmaceuticals has received approval from the Institutional Review Board (IRB) to initiate Phase III clinical trial protocol of its new topical non-steroidal anti-inflammatory drug (NSAID) candidate, Impracor. Impracor is based ...

Tags: Drug Formulation Impracor, Medicine

Glenmark Generics Is Recalling Gabapentin, Pravastatin and Topiramate Drugs

May 27, 2013

Glenmark Generics, a subsidiary of Glenmark Pharmaceuticals, is recalling several lots of Gabapentin, Pravastatin, and Topiramate drugs from across the US markets primarily due to “odd smell.” The US Food and Drug ...

Tags: Glenmark Generics, Drugs

Vertellus Specialties Has Upgraded Its Facility in Antwerp, Belgium

May 7, 2013

Vertellus Specialties has upgraded its facility in Antwerp, Belgium, to manufacture niacin (nicotinic acid) for pharmaceutical use. Major changes at the plant comprise upgrades and validation of critical equipment, manufacturing ...

Tags: Vertellus, Belgium Facility

The USFDA Approval Adds to Expansion of The Vascepa Manufacturing Supply Chain

Apr 23, 2013

The USFDA has approved Amarin supplemental new drug application for Chemport as additional Vascepa active pharmaceutical ingredient supplier. The approval adds to the company's planned expansion of the Vascepa manufacturing supply chain ...

Tags: FDA, Pharmaceutical Ingredient Supplier

ScinoPharm and Foresee Pharmaceuticals Have Signed an Agreement

Feb 1, 2013

ScinoPharm and Foresee Pharmaceuticals have signed an agreement to form a joint venture for developing a series of peptide injectable drugs with the first being a new oncological Leuprolide injectable drug used for treating prostate cancer. ...

Tags: ScinoPharm, Foresee Pharmaceuticals, joint venture

Omkar Speciality Chemicals Is Planning to Invest INR250m to Expand The Production Capacity

Dec 25, 2012

Omkar Speciality Chemicals is planning to invest INR250m ($4.67m) to expand the production capacity from current 1,700 to 1,950 tons at its active pharmaceutical ingredient (API) facility in Badlapur, Maharashtra, India. Omkar Speciality ...

Tags: Omkar, production capacity, Speciality Chemicals

Bend Research Has Won Two New US Patents

Dec 4, 2012

Bend Research has won two new US patents covering the technology that increases the oral bioavailability of low-solubility drugs. The patents protect compositions and processes for making spray-dried dispersions (SDDs) made with an ...

Tags: patent, pharmaceutical technology, low-solubility drug

Hospira Has Entered Into a Definitive Agreement

Nov 28, 2012

Hospira has entered into a definitive agreement to purchase Orchid Chemicals&Pharmaceuticals'FDA-approved active pharmaceutical ingredient(API)manufacturing and Chennai-based R&D facilities for approximately$200m. The acquisition will ...

Tags: Orchid Chemicals, Hospira, active pharmaceutical ingredient

Atorvastatin Is Used to Treat High Cholesterol and Prevention of Heart Attack

Jul 18, 2012

Ind-Swift, an Indian pharmaceutical company, in collaboration with its marketing partner Wockhardt UK launched the generic formulations of atorvastatin drug in UK on the first day of its patent expiry. Atorvastatin (lipitor) is used for ...

Tags: atorvastatin, lipitor, Ind-Swift

Goose Has Launched API Manager to Manage Complex Projects and Improve Delivery Quality

May 30, 2012

India's pharmaceutical business solutions provider, Goose, has launched Active Pharmaceutical Ingredient (API) Manager, that enables pharma companies manage complex projects and improve delivery quality, yield. The API Manager is an ...

Tags: pharmaceutical, API, Active Pharmaceutical Ingredient, manage

active pharmaceutical ingredient

Related Products